IRADIMED CORP (IRMD) Institutional Ownership

IRMD is currently held by 2 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $44.42M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $42.42M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's IRMD position is now estimated to be worth approximately $40.14M, representing an estimated loss of -5.37% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Polen Capital Management, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward IRADIMED CORP (IRMD).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20262$44,419,754461,456
Q4 20252$47,015,715483,303
Q3 20252$36,805,446517,221
Q2 20252$30,893,552516,701
Q1 20251$26,329,846501,712
Q4 20241$28,215,660513,012
Q3 20241$27,131,354539,498
Q2 20243$37,644,716856,730
Q1 20242$12,298,427852,244
Q4 20232$13,176,733857,212
Q3 20232$12,315,999851,912
Q2 20232$13,251,784859,412